Wang, Y.; Xu, B.; Ma, S.; Wang, H.; Shang, L.; Zhu, C.; Ye, S.
Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions. Int. J. Mol. Sci. 2022, 23, 2392.
https://doi.org/10.3390/ijms23042392
AMA Style
Wang Y, Xu B, Ma S, Wang H, Shang L, Zhu C, Ye S.
Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions. International Journal of Molecular Sciences. 2022; 23(4):2392.
https://doi.org/10.3390/ijms23042392
Chicago/Turabian Style
Wang, Yaxin, Binghong Xu, Sen Ma, Hao Wang, Luqing Shang, Cheng Zhu, and Sheng Ye.
2022. "Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions" International Journal of Molecular Sciences 23, no. 4: 2392.
https://doi.org/10.3390/ijms23042392
APA Style
Wang, Y., Xu, B., Ma, S., Wang, H., Shang, L., Zhu, C., & Ye, S.
(2022). Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions. International Journal of Molecular Sciences, 23(4), 2392.
https://doi.org/10.3390/ijms23042392